Código QR (código de barras bidimensional)

Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia

IntroductionB-cell acute lymphoblastic leukemia (B-ALL) is characterized by the clonal expansion of immature lymphoblastic cells. Treating patients with disease relapse is challenging, especially after allogeneic stem cell transplantation (aSCT). Although the CD19xCD3 bispecific antibody (bsAb) blin...

ver descrição completa

Na minha lista:
Principais autores: Joseph Kauer, Fabian Vogt, Sebastian Hörner, Valentin Schmidt, Carsten Müller-Tidow, Simon Raffel, Helmut R. Salih, Gundram Jung, Martin Pflügler
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-02-01
coleção:Frontiers in Immunology
Assuntos:
acute lymphoblastic leukemia
bispecific antibodies
CD19
gammadelta T cells
immunotherapy
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1728424/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados